Larion Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.50 M
as on 16-11-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 16-11-2024
- Revenue -10.13%
(FY 2023)
- Profit -19.57%
(FY 2023)
- Ebitda 1.02%
(FY 2023)
- Net Worth 16.61%
(FY 2023)
- Total Assets -4.80%
(FY 2023)
About Larion Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Ramaiyan Natesavalavan, Saravanan Nambiyappan, Guruvuthevar Selvaraj, and One other member serve as directors at the Company.
- CIN/LLPIN
U52310TN2008PTC066974
- Company No.
066974
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Larion Life Sciences Private Limited offer?
Larion Life Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Syrup, Antihistamines, Anti Inflammatory Drugs, Methylprednisolone Injection.
Who are the key members and board of directors at Larion Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramaiyan Natesavalavan  | Director | 25-Mar-2008 | Current |
| Saravanan Nambiyappan | Director | 25-Mar-2008 | Current |
| Guruvuthevar Selvaraj | Director | 25-Mar-2008 | Current |
| Srikanth | Director | 25-Mar-2008 | Current |
Financial Performance of Larion Life Sciences.
Larion Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.13% decrease. The company also saw a substantial fall in profitability, with a 19.57% decrease in profit. The company's net worth Soared by an impressive increase of 16.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Larion Life Sciences?
In 2023, Larion Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Larivin Pharma Private LimitedActive 1 year 6 monthsRamaiyan Natesavalavan and Saravanan Nambiyappan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Apr 2009 | ₹2.00 Cr | Open |
How Many Employees Work at Larion Life Sciences?
Larion Life Sciences has a workforce of 105 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Larion Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Larion Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
